Shares of Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) dropped 1.8% during mid-day trading on Wednesday . The company traded as low as $0.57 and last traded at $0.57. Approximately 18,721 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 1,286,615 shares. The stock had previously closed at $0.58.
Elevai Labs Stock Down 1.8 %
The business has a 50-day moving average price of $0.70.
Elevai Labs (NASDAQ:ELAB – Get Free Report) last announced its quarterly earnings data on Friday, March 29th. The company reported ($0.08) earnings per share (EPS) for the quarter. The firm had revenue of $0.70 million during the quarter.
Elevai Labs Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
See Also
- Five stocks we like better than Elevai Labs
- Low PE Growth Stocks: Unlocking Investment Opportunities
- United Airlines Soars on Earnings Beat
- How to invest in marijuana stocks in 7 steps
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
